课题基金 / 基金详情

Propionic acid use in agriculture and food production is driving evolution of novel Escherichia coli pathotypes

Propionic acid use in agriculture and food production is driving evolution of novel Escherichia coli pathotypes
丙酸在农业和食品生产中的使用正在推动新型大肠杆菌致病型的进化
批准号:
BB/P003281/1
负责人:
Daniel Wall
金额:
$48.57万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --

项目摘要

项目成果

Daniel Wall的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Emerging multidrug resistant strains of bacteria have forced both the agricultural and food production industries to rethink the use of antibiotics as a means of preventing both food spoilage and transmission of pathogens into the food chain. Alternative anti-microbial compounds are increasingly used such as short chain fatty acids (SCFA), commonly found in the colon but with anti-microbial properties. SCFA production and use has increased greatly in the past 40 years, particularly in the Western world, with the production of one such SCFA, propionic acid (PA), now worth approximately £1.2 billion per year and rising. PA efficacy and low cost allows farmers to treat grain and animal feed while reducing antibiotic use, resulting in PA being proposed as a solution in developing countries to antibiotic overuse. PA has proven highly successful in poultry production where through feed and water addition it has reduced carriage of Salmonella and Campylobacter, common causes of food borne sickness in the UK. PA has also proved highly popular as it is non-toxic to humans with few, if any, side effects. PA therefore can be added to foodstuffs including cakes, bread and preserves at up to 1% total weight of the food. The Western diet now contains increasing levels of food additives whose addition while prolonging the shelf life of food and reducing food borne disease, has also coincided with worrying increases in the prevalence of debilitating gut diseases. Inflammatory bowel diseases such as Crohn's Disease (CD) and ulcerative colitis (UC) while linked to underlying genetic conditions are exacerbated by dietary and other factors, such as bacteria in the intestine. A definitive explanation to link these genetic, dietary and microbial factors together has to date proved elusive. In this proposal we will show that PA is facilitating the transfer of pathogenic E. coli that are exposed to PA in poultry, to the PA rich environment of the human intestine. Adherent and invasive E. coli (AIEC) are consistently isolated from the intestine of CD sufferers. These bacteria are unusual in that they lack toxins or other factors that would set them apart as pathogens. However unlike most other bacteria AIEC can grow and survive on the preservative PA which in time induces significant changes in the behaviour of AIEC. These PA induced changes include increased invasion of cells of the intestine, persistence within these cells and an ability to form structures called biofilms that enable the bacteria to resist antibiotics at higher concentrations and for longer. When this adaptation to PA in the lab is looked at from an agricultural perspective it can be seen that if AIEC were to encounter PA in the environment it would prepare or adapt them to the human intestine where levels of PA are high and restrictive for most pathogens, particular in the lower intestine or colon. However, AIEC establish infection throughout the human intestine, even in places where Salmonella and Campylobacter cannot. AIEC therefore appear well adapted to PA begging the question of how and where this adaptation occurred. Significantly AIEC are thought to be related to pathogens called avian pathogenic E. coli (APEC) that are found in birds such as chickens. These APECs are increasingly being recognized as causative agents of human disease with E. coli isolated from infections throughout the body, including the urinary tract and meningitis, bearing striking similarities to APECs. This proposal will seek to establish if high levels of PA use in the poultry industry and elsewhere is contributing to the evolution of pathogens that are now capable of causing disease in the human intestine. This proposal will for the first time show a definitive link between Crohn's Disease, the Western diet and AIEC, and identify propionic acid as being a facilitator in driving this relationship.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1101/2020.03.13.987164
发表时间: 2020-03
期刊: bioRxiv
影响因子: --
作者: [Heather Hulme;Lynsey M. Meikle;Nicole Strittmatter;J. Swales;G. Hamm;S. Brown;S. Milling;A. MacDonald;R. Goodwin;R. Burchmore;D. Wall]
通讯作者: Heather Hulme;Lynsey M. Meikle;Nicole Strittmatter;J. Swales;G. Hamm;S. Brown;S. Milling;A. MacDonald;R. Goodwin;R. Burchmore;D. Wall
DOI: 10.1021/jasms.1c00298
发表时间: 2022-04-06
期刊: JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
影响因子: 3.2
作者: [Hulme, Heather, Meikle, Lynsey M., Strittmatter, Nicole, Swales, John, Hamm, Gregory, Brown, Sheila L., Milling, Simon, MacDonald, Andrew S., Goodwin, Richard J. A., Burchmore, Richard, Wall, Daniel M.]
通讯作者: Wall, Daniel M.
SipA Activation of Caspase-3 Is a Decisive Mediator of Host Cell Survival at Early Stages of Salmonella enterica Serovar Typhimurium Infection.
SipA 激活 Caspase-3 是肠沙门氏菌鼠伤寒血清型感染早期宿主细胞存活的决定性介质。
DOI: 10.1128/iai.00393-17
发表时间: 2017-09
期刊: Infection and immunity
影响因子: 3.1
作者: [McIntosh A, Meikle LM, Ormsby MJ, McCormick BA, Christie JM, Brewer JM, Roberts M, Wall DM]
通讯作者: Wall DM
DOI: 10.1002/eji.202048913
发表时间: 2021-12
期刊: European journal of immunology
影响因子: 5.4
作者: []
通讯作者:
7
    Lachnospiraceae in the gut microbiome and their role in disease
    • 批准号:
      BB/V001876/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $56.73万
    • 财政年份:
      2021
    • 负责人:
      Daniel Wall
    • 依托单位:
    Building Capacity in Linguistics, STEM and Technology through the Documentation of the North Slope Dialect of Inupiaq, an endangered Native Alaskan language
    • 批准号:
      1563665
    • 项目类别:
      Standard Grant
    • 资助金额:
      $24.61万
    • 财政年份:
      2016
    • 负责人:
      Daniel Wall
    • 依托单位:
    Survival and dissemination of enteric pathogens through activation and subsequent inhibition of programmed cell death pathways
    • 批准号:
      BB/K008005/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $55.38万
    • 财政年份:
      2013
    • 负责人:
      Daniel Wall
    • 依托单位:
    Cell-to-Cell Transfer of Bacterial Lipoproteins
    • 批准号:
      0848141
    • 项目类别:
      Continuing Grant
    • 资助金额:
      $51.43万
    • 财政年份:
      2009
    • 负责人:
      Daniel Wall
    • 依托单位:
    国内基金
    海外基金
    棕榈酸Palmitic acid通过靶向JAK-STAT通路促进致病性Th17细胞分化在儿童性系统性红斑狼疮中的作用及机制研究
    • 批准号:
      2026JJ81716
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      唐金玲
    • 依托单位:
    基于F/IGF1R/PKC ζ 通路研究夏枯草中 Mesonolic acid B抑制RSV感染性肺炎的 作用机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      唐维
    • 依托单位:
    Quinic acid通过抑制肠道菌群代谢产物脱氧胆酸调节巨噬细胞M1向M2极化改善动脉粥样硬化的机制研究
    脂肪酸α-dimorphecolicacid抑制NF-κB信号介导的小胶质细胞炎症缓解多发性硬化的免疫代谢调控机制研究
    • 批准号:
      QN25H310018
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      杨帆
    • 依托单位: